Proactive Investors - Run By Investors For Investors

Breakfast News - Pelatro, Miriad Advertising, Sirius Petroleum

Breakfast News - Pelatro, Miriad Advertising, Sirius Petroleum

Dish of the day

Pelatro AIM (LON:PTRO)— The precision marketing software specialist. Raising £3.8m new money plus £0.6m vendor sale. 62.5p. Mkt cap £15.2m. HYJun17  revenues increased to US$1.55m from US$0.2m and profit before tax increased to £1.0m from a small loss in the comparable period.

Miriad Advertising AIM (LON:MIRI) —Global video advertising company engaged in the development of native in-video advertising. 2016 rev £0.7m and £7.3m operating loss. Offer raising £26.2m with market cap of £63.2m.

Sirius Petroleum AIM (LON:SRSP)  —RTO. Becoming an OpCo in the Ororo Field  Nigeria. Raising £7.2m/ Mkt Cap £35.6m.


Off the menu    No Leavers Today


What’s cooking in the IPO kitchen?

 NEX Exchange

 Whetstone Capital No raise. Due 5 January 2018. Mkt Cap £1.6m.  Investment Vehicle for small and mid sized private and public companies.



Erris Resources plc—a mineral exploration and development company currently focused on two geographic areas. Offer TBC, expected 21 December 2017

CIP Merchant Capital—Closed ended investment Company. Sector focus oil & gas, healthcare, pharma, and real estate. Raising £55m.  Due 21 Dec

Panthera Resources— The Company was established to act as a holding company for Indo Gold Limited, an unlisted Australian registered company. The Company aims to explore and develop gold assets in India and West Africa. No raise. Expected 21 Dec

Sumo Group—one of the UK's largest independent developers of AAA-rated video games providing both turnkey and co-development solutions, including initial concept and pre-production. Raising £38.45m and vendor sale of £39,7m. Mkt cap £145m.

Bushveld Minerals —RTO of Bushveld Vametco and therefore 78.8% of Strategic Minerals Corporation, the intermediate holding company that owns a 75 per cent. interest in the Vametco Vanadium Mine.

Eqtec—Company with access to a proprietary advanced gasification technology used in industrial size power plants to convert waste into synthetic gas to generate electricity.  Raising £1.6m. Mkt Cap £8.7m. Due 21 Dec.

Volex (LON:VLX) —The global provider of cable assemblies is proposing to move from the main market to AIM on 19 January. £71m market cap. FYMar18E rev £241.5m and £7.19m PBT


OnTheMarket—Intention to float on AIM to raise c.£50m which will be used to fund the growth of the portal, already the third biggest UK residential property portal provider. Expected valuation £200m to £250m.


Main Market Specialist Fund Segment

Sure Ventures –Raising  up to £50m at £1. Focus on FinTech, IoT and Augmented/Virtual Reality. Due 22 Dec.

Tufton Oceanic Assets  -  intends to invest in a diversified portfolio of secondhand commercial sea-going vessels . Aiming to raise over $100m. Due 20 Dec


Main Market Standard Listing

Pennpetro Energy Independent oil and gas co with an initial focus on Texas. Due 21 December. No funds being raised at this point.


Main Market Premium Listing

GEMS Education—report by Reuters that the private schools group is seeking a $4.5bn to $5bn London float in 2018. FYAug17 rev $926.2m and adjusted EBITDA $261.6m.

Greensphere Capital POSTPONED -$500m raise.  Aims to provide Shareholders with an attractive yield from a portfolio of sustainable infrastructure assets diversified by geographies and sectors and to realise long-term growth  capital value.  Due 20 Dec

Vivo Energy—The Africa-focused company, which operates around 1,800 Shell forecourts across 16 countries  reported by City A.M. to be preparing for a London float next year


Breakfast buffet

ECO Animal Health (LON:EAH) 592.5p £389.6m

Subsidiary ECO Animal Health Limited (ECO) has received a marketing authorisation from the Animal Feeds, Veterinary Drugs and Biologics Control Division of the Bureau of Animal Industry of the Department of Agriculture in the Republic of the Philippines for the use of Aivlosin® 625 mg/g water soluble granules in chickens laying eggs for human consumption.

This approval allows ECO to start selling Aivlosin® in the Philippines for the medication of drinking water for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption, with a zero day drug withdrawal period for eggs. ECO has begun the process of submitting the EU approved Aivlosin® regulatory files for the treatment of layers in numerous other key egg producing markets. FYMar18E rev £69.74m, PBT £16.49m, div 8.66p.


European Metals Holdings (LON:EMH) 36.9p £51.04m

European Metals Holdings Limited announced that the Cinovec South Resource had been added to the Czech State resource register, the first step in the process for the granting of a mining permit.

The Company is now pleased to announce that the Cinovec NorthWest Resource has also been added to the Czech State resource register.

 Additionally, recent optimisation test work has demonstrated the ability to reduce roast temperatures and duration which can result in significant cost savings both in CAPEX and OPEX.”


Sareum Holdings* (LON:SAR.) 0.87p £23.88m

“The specialist cancer drug discovery and development business, is pleased to announce that the Japanese Patent Office has granted a patent for inventions associated with Sareum's TYK2 Kinase Inhibitor Programme, and that the Chinese Patent Office has issued notification that such a patent will be granted subject to certain formalities being completed.

This patent describes compounds that inhibit JAK kinase enzyme function, in particular TYK2 kinase. It also describes the use of these compounds in the treatment of disease mediated by these kinase enzymes, including autoimmune diseases such as multiple sclerosis, psoriasis and inflammatory bowel disease.”

"Enhances the value of this programme as we progress discussions with potential licensing partners."


Nichols (LON:NICL.L) 1,425p £525m


FYDec17 update. “We anticipate Group sales for the year ending 31 December 2017 to continue the strong trend reported at the half year. This sales performance is again being delivered from both our UK and international business.  UK sales of the Vimto brand are 9.0% ahead of the prior year (as at November 2017). This performance is significantly ahead of the UK market growth of 2.3% (Nielsen year to date 2 December 2017). As previously reported, this strong sales performance helps mitigate the margin impact from the increased input costs affecting the industry.”

Supply route to Yemen blockaded. Sales expected to be ahead of current year and profit in line Vs 7% EPS growth  as per current consensus forecasts.


Epwin (LON:EPWN) 81p £115.8m

The low maintenance building products manufacturer, supplying businesses in the Repair, Maintenance and Improvement ("RMI"), new build and social housing sectors, announces that it has disposed of one of its subsidiaries, Indigo Products Limited to Indigo Acquisitions Limited. Total consideration of £1 to Indigo Acquisitions Limited, follows the insolvency of Entu (UK) Plc earlier this year. Indigo was primarily engaged in fabricating window frames for Entu (UK) plc. During the 10 month period to 31 October 2017, Indigo had revenues of £12.6m and a loss before tax of £2.7m.  New three year exclusive supply agreement for extruded plastic products has been agreed with the purchaser.  Trading in line with expectations for FYDec17. Consensus rev £295.9m, PBT £21m, div 6.7p


 Shearwater Group (LON:SWG) 3.13p £30.14m

“The digital resilience group, is pleased to announce its unaudited interim results for the six months ended 30 September 2017. The unaudited interim results of the Group reflect approximately 4.7 months of trading from SecurEnvoy (acquired in May 2017) and 2.2 months of trading from Newable Consulting (acquired in July 2017 and rebranded Xcina Consulting).  Trading in both businesses continues to be in line with the Board's expectations and since acquisition have generated in aggregate £2.1m of revenue and contributed £0.9m of underlying EBITDA to the Group in the period.” Cash of £2.1m. “Since 30 September 2017, trading has continued in line with the Board's expectations, and we are encouraged by the progress both businesses are making as part of the Group.” Could see no forecasts.


Rambler Metals & Mining  (LON:RMM) 8.5p £43.98m

“Rambler Metals and Mining plc (TSXV: RAB, AIM: RMM) ("Rambler" or "the Company"), a copper and gold producer, explorer, and developer is pleased to announced that for the month of November 2017 it processed 33,870 tonnes of ore from the Ming Mine through the Nugget Pond mill, averaging 1,221 metric tonnes per day ("mtpd") during operational hours. November's performance represents record monthly throughput for the operation. “

“This marks just the beginning of the next phase of growth for Rambler.  This deposit has the ability to sustain a high throughput over a long mine life, currently 20 years. “ FYDec17eE rev £20.94m and £3.45m loss.


Redhall Group (LON:RHL) 8.75p £29.13m

The Jordan Manufacturing business has secured a key role in support of Cavendish Nuclear, a subsidiary of Babcock International Group PLC, for the delivery of specialist handling and containment systems to process nuclear material for Sellafield Ltd. Babcock been awarded a 10-year contract with Sellafield. Worth up to £95m over the first three years, Cavendish Nuclear will provide Sellafield with design, manufacture and supply of complex bespoke equipment for the treatment and management of nuclear materials. Jordan Manufacturing has secured, through a Teaming Agreement with Cavendish Nuclear, a key role in the delivery of this contract and will manufacture containment systems and associated process equipment. It is anticipated that this will be worth up to £18 million over the first three years. FYSep18E rev £51.3m, PBT £3.4m.


NWF Group (LON:NWF) 162.5p £79.1,m

HYNov17 update from the specialist agricultural and distribution business delivering feed, food and fuel across the UK.

The Group reports that trading for the half year ended 30 November 2017 was ahead of the prior year and the Board remains confident of delivering its full year expectations. Net debt was also lower than at 30 November 2016. 


FYMay18E rev £575.5m and £8.55m PBT, yield c.3.9%, PE c. 12x.



This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use